science

Immunomedics

Immunomedics is a science topic covered in the lgStudy science library. This page brings together a partial reference excerpt, illustrations, worked examples, real-world applications and a short study plan, so you can understand Immunomedics rather than just read about it. In short: Immunomedics was a biotechnology company focused on the development of antibody-drug conjugates for the treatment of cancer. In 2020, the company was acquired by Gilead Sciences for $21 billion.

Key takeaways

Immunomedics belongs to science; place it in that map before memorising details.
Learn the definition first, then one example that makes the definition concrete.
Connect Immunomedics to a quantity you can measure, compute or draw — that is where exam questions come from.
Reproduce the core statement of Immunomedics from memory before moving on to harder problems.

Reference excerpt

Immunomedics was a biotechnology company focused on the development of antibody-drug conjugates for the treatment of cancer. In 2020, the company was acquired by Gilead Sciences for $21 billion.

History Immunomedics was founded in July 1982 by David M. Goldenberg. Michael Pehl was named CEO in December 2017 but left for personal reasons in February 2019. At that time, Dr. Behzad Aghazadeh was named Executive Chairman. In October 2020, Gilead Sciences acquired the company. In March 2022, Gilead announced the closing of the former Immunomedics facility in Morris Plains.

Products Epratuzumab is a humanized anti-CD22 monoclonal antibody in phase III trials for pediatric leukemia. Sacituzumab govitecan (IMMU-132 / Trodelvy) is an anti-Trop-2-SN-38 antibody-drug conjugate for breast cancer and solid tumors. It was approved in April 2020 by the FDA for the treatment of adult patients with metastatic triple-negative breast cancer (mTNBC) who have received at least two prior therapies for patients with relapsed or refractory metastatic disease. In 2017, the company scrapped a licensing deal for the drug with Seagen that led to the resignation of founder David M. Goldenberg. Labetuzumab (IMMU-130) is an anti-CEACAM5-SN-38 antibody-drug conjugate in clinical trials for colorectal cancer. Veltuzumab is an anti-CD20 monoclonal antibody for treatment of cancer. Milatuzumab (IMMU-110) is an anti-CD74 monoclonal antibody for autoimmune diseases. IMMU-114 is an anti-HLA-DR for hematological cancers.

References

Worked examples

Example 1 — a first encounter with Immunomedics

Start with the simplest possible case. Write down what Immunomedics claims or describes in one sentence, then invent the smallest concrete situation in which that sentence is true. In science, the smallest case is usually a single object, a single equation or a single measurement. Check that every symbol or term in your sentence has a meaning in that case.

Example 2 — changing one variable

Take the situation from Example 1 and change exactly one quantity: double it, halve it, or set it to zero. Predict what should happen to Immunomedics before you calculate. Comparing your prediction with the result is the fastest way to find out whether you understand the idea or only the words.

Example 3 — an exam-style question

Typical questions about Immunomedics ask you to (a) state it precisely, (b) apply it to given data, and (c) explain a limitation. Practise writing all three answers in under five minutes; the third part is what separates a full-mark answer from an average one.

Applications of Immunomedics

In research: Immunomedics appears in science research whenever the underlying quantities have to be modelled precisely. Papers usually cite it as a starting assumption and then explore where it breaks down.
In technology and industry: Engineering practice reuses Immunomedics in design rules, simulations and safety margins. Knowing the idea lets you read a specification sheet and understand why the numbers look the way they do.
In the classroom: Immunomedics is common in secondary-school and first-year university syllabi. It links to neighbouring topics 1982 establishments in New Jersey, 2020 mergers and acquisitions, American companies established in 1982, so understanding it makes those chapters shorter.
In everyday life: Look for Immunomedics outside the textbook — in sport, cooking, traffic, electronics or the sky above you. An example you found yourself is remembered far longer than one you were given.

Ask Teacher Smith questions about this articleOpens your AI tutor with a question about “Immunomedics” →

Affiliate

Preply — study more efficiently by working with a personal tutor. 50% off.

How to study Immunomedics in 20 minutes

Read the reference excerpt below once, without taking notes.
Close the page and write down what Immunomedics means in your own words.
Compare your version with the excerpt and mark what you missed.
Work through the three examples above with pen and paper.
Explain Immunomedics out loud to somebody else — or to Teacher Smith in the lgStudy chat.

Frequently asked questions

What is Immunomedics in simple terms?

Immunomedics was a biotechnology company focused on the development of antibody-drug conjugates for the treatment of cancer. In 2020, the company was acquired by Gilead Sciences for $21 billion.

Why does Immunomedics matter?

Because it connects several science ideas at once: it gives you a definition you can apply, a quantity you can calculate, and a way to check whether a result is plausible.

How should I study Immunomedics?

Read the excerpt, restate it from memory, then work through the examples and applications listed on this page. The five-step study plan above takes about twenty minutes.

What does this page cover?

It gives you a compact reference excerpt plus original lgStudy explanations, examples, applications and study material on Immunomedics.